*Aurinia Pharmaceuticals Inc.

Changing the course of autoimmune disease

Inspired by patients. Driven to make an impact.

Aurinia’s Response to COVID-19

View

Latest News

October 14, 2020 • 12:00am EDT

Aurinia Pharmaceuticals Announces Launch of Lupus Nephritis Disease-State Awareness Initiative for Healthcare Professionals, TimeIsNephrons.com

Read Press Release View All News

October 2, 2020 • 12:00am EDT

Aurinia Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read Press Release View All News

September 28, 2020 • 12:00am EDT

Aurinia Completes Final Patient Treatment in AUDREY Phase 2/3 Clinical Trial of Voclosporin Ophthalmic Solution for Dry Eye Syndrome

Read Press Release View All News